Copyright Reports & Markets. All rights reserved.

Global Transdermal Patch Drug Delivery System Market Size, Status and Forecast 2019-2025

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Transdermal Patch Drug Delivery System Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Shunt Way
      • 1.4.3 Intercellular Lipid Structure Pathway
      • 1.4.4 Trans-cellular Pathway
    • 1.5 Market by Application
      • 1.5.1 Global Transdermal Patch Drug Delivery System Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Home Care
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Transdermal Patch Drug Delivery System Market Size
    • 2.2 Transdermal Patch Drug Delivery System Growth Trends by Regions
      • 2.2.1 Transdermal Patch Drug Delivery System Market Size by Regions (2019-2025)
      • 2.2.2 Transdermal Patch Drug Delivery System Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Transdermal Patch Drug Delivery System Market Size by by Players
      • 3.1.1 Global Transdermal Patch Drug Delivery System Revenue by by Players (2014-2019)
      • 3.1.2 Global Transdermal Patch Drug Delivery System Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Transdermal Patch Drug Delivery System Market Concentration Ratio (CR5 and HHI)
    • 3.2 Transdermal Patch Drug Delivery System Key Players Head office and Area Served
    • 3.3 Key Players Transdermal Patch Drug Delivery System Product/Solution/Service
    • 3.4 Date of Enter into Transdermal Patch Drug Delivery System Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Transdermal Patch Drug Delivery System Market Size by Type (2014-2019)
    • 4.2 Global Transdermal Patch Drug Delivery System Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Transdermal Patch Drug Delivery System Market Size (2014-2019)
    • 5.2 Transdermal Patch Drug Delivery System Key Players in North America
    • 5.3 North America Transdermal Patch Drug Delivery System Market Size by Type
    • 5.4 North America Transdermal Patch Drug Delivery System Market Size by Application

    6 Europe

    • 6.1 Europe Transdermal Patch Drug Delivery System Market Size (2014-2019)
    • 6.2 Transdermal Patch Drug Delivery System Key Players in Europe
    • 6.3 Europe Transdermal Patch Drug Delivery System Market Size by Type
    • 6.4 Europe Transdermal Patch Drug Delivery System Market Size by Application

    7 China

    • 7.1 China Transdermal Patch Drug Delivery System Market Size (2014-2019)
    • 7.2 Transdermal Patch Drug Delivery System Key Players in China
    • 7.3 China Transdermal Patch Drug Delivery System Market Size by Type
    • 7.4 China Transdermal Patch Drug Delivery System Market Size by Application

    8 Japan

    • 8.1 Japan Transdermal Patch Drug Delivery System Market Size (2014-2019)
    • 8.2 Transdermal Patch Drug Delivery System Key Players in Japan
    • 8.3 Japan Transdermal Patch Drug Delivery System Market Size by Type
    • 8.4 Japan Transdermal Patch Drug Delivery System Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Transdermal Patch Drug Delivery System Market Size (2014-2019)
    • 9.2 Transdermal Patch Drug Delivery System Key Players in Southeast Asia
    • 9.3 Southeast Asia Transdermal Patch Drug Delivery System Market Size by Type
    • 9.4 Southeast Asia Transdermal Patch Drug Delivery System Market Size by Application

    10 India

    • 10.1 India Transdermal Patch Drug Delivery System Market Size (2014-2019)
    • 10.2 Transdermal Patch Drug Delivery System Key Players in India
    • 10.3 India Transdermal Patch Drug Delivery System Market Size by Type
    • 10.4 India Transdermal Patch Drug Delivery System Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Transdermal Patch Drug Delivery System Market Size (2014-2019)
    • 11.2 Transdermal Patch Drug Delivery System Key Players in Central & South America
    • 11.3 Central & South America Transdermal Patch Drug Delivery System Market Size by Type
    • 11.4 Central & South America Transdermal Patch Drug Delivery System Market Size by Application

    12 International Players Profiles

    • 12.1 Hisamitsu Pharmaceutical
      • 12.1.1 Hisamitsu Pharmaceutical Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Transdermal Patch Drug Delivery System Introduction
      • 12.1.4 Hisamitsu Pharmaceutical Revenue in Transdermal Patch Drug Delivery System Business (2014-2019))
      • 12.1.5 Hisamitsu Pharmaceutical Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Transdermal Patch Drug Delivery System Introduction
      • 12.2.4 Novartis Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 ProSolus
      • 12.3.1 ProSolus Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Transdermal Patch Drug Delivery System Introduction
      • 12.3.4 ProSolus Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
      • 12.3.5 ProSolus Recent Development
    • 12.4 Tapemark
      • 12.4.1 Tapemark Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Transdermal Patch Drug Delivery System Introduction
      • 12.4.4 Tapemark Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
      • 12.4.5 Tapemark Recent Development
    • 12.5 Tesa Labtec
      • 12.5.1 Tesa Labtec Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Transdermal Patch Drug Delivery System Introduction
      • 12.5.4 Tesa Labtec Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
      • 12.5.5 Tesa Labtec Recent Development
    • 12.6 NITTO DENKO CORPORATION
      • 12.6.1 NITTO DENKO CORPORATION Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Transdermal Patch Drug Delivery System Introduction
      • 12.6.4 NITTO DENKO CORPORATION Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
      • 12.6.5 NITTO DENKO CORPORATION Recent Development
    • 12.7 Noven Pharmaceuticals
      • 12.7.1 Noven Pharmaceuticals Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Transdermal Patch Drug Delivery System Introduction
      • 12.7.4 Noven Pharmaceuticals Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
      • 12.7.5 Noven Pharmaceuticals Recent Development
    • 12.8 LTS Lohmann Therapie-Systeme
      • 12.8.1 LTS Lohmann Therapie-Systeme Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Transdermal Patch Drug Delivery System Introduction
      • 12.8.4 LTS Lohmann Therapie-Systeme Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
      • 12.8.5 LTS Lohmann Therapie-Systeme Recent Development
    • 12.9 Medherant
      • 12.9.1 Medherant Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Transdermal Patch Drug Delivery System Introduction
      • 12.9.4 Medherant Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
      • 12.9.5 Medherant Recent Development
    • 12.10 Corium
      • 12.10.1 Corium Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Transdermal Patch Drug Delivery System Introduction
      • 12.10.4 Corium Revenue in Transdermal Patch Drug Delivery System Business (2014-2019)
      • 12.10.5 Corium Recent Development
    • 12.11 Antares Pharma
    • 12.12 Syntropharma
    • 12.13 Teikoku Pharma
    • 12.14 Mylan
    • 12.15 Actavis
    • 12.16 Mundipharma
    • 12.17 Henan Lingrui Pharmaceutical
    • 12.18 Changzhou Siyao
    • 12.19 Rfl Pharmaceutical

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Transdermal Patch Drug Delivery System status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Transdermal Patch Drug Delivery System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Hisamitsu Pharmaceutical
      Novartis
      ProSolus
      Tapemark
      Tesa Labtec
      NITTO DENKO CORPORATION
      Noven Pharmaceuticals
      LTS Lohmann Therapie-Systeme
      Medherant
      Corium
      Antares Pharma
      Syntropharma
      Teikoku Pharma
      Mylan
      Actavis
      Mundipharma
      Henan Lingrui Pharmaceutical
      Changzhou Siyao
      Rfl Pharmaceutical

      Market segment by Type, the product can be split into
      Shunt Way
      Intercellular Lipid Structure Pathway
      Trans-cellular Pathway

      Market segment by Application, split into
      Hospital
      Clinic
      Home Care
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Transdermal Patch Drug Delivery System status, future forecast, growth opportunity, key market and key players.
      To present the Transdermal Patch Drug Delivery System development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Transdermal Patch Drug Delivery System are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now